Insider · CIK 0001542650
Lawton Alison Frances
Reports to the SEC for 9 companies · NEW YORK, NY
Transactions
50
Companies
9
Filings
20
CIK
0001542650
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-21 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2025-05-22 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2024-06-10 | XFORX4 Pharmaceuticals, IncA Award | — |
| 2024-05-23 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2023-09-11 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2023-06-22 | SYRESpyre Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-13 | XFORX4 Pharmaceuticals, IncA Award | — |
| 2022-06-28 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2022-06-07 | SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award | — |
| 2022-06-06 | XFORX4 Pharmaceuticals, IncA Award | — |
| 2021-06-08 | SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award | — |
| 2021-06-02 | XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award | +$57K |
| 2021-06-01 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2020-12-22 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2020-12-15 | SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award | — |
| 2020-10-05 | XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award | — |
| 2020-04-15 | Kaleido Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2020-02-28 | Kaleido Biosciences, Inc.Restricted Stock UnitsA Award | — |
| 2019-11-15 | Kaleido Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2019-06-21 | VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-03-04 | Kaleido Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2018-06-11 | VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award | — |
| 2017-06-13 | VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award | — |
| 2017-03-01 | CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer | −$56.7K |
| 2017-03-01 | CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer | −$6,777.4 |
| 2017-03-01 | CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer | −$358K |
| 2017-01-03 | CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award | +$20K |
| 2016-06-14 | VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award | — |
| 2016-05-10 | CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award | — |
| 2016-03-11 | CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award | — |
| 2015-06-12 | VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)D Disposition to Issuer | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCJ Other | −$481K |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)D Disposition to Issuer | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)D Disposition to Issuer | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)D Disposition to Issuer | — |
| 2015-01-21 | CUBIST PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer | — |
| 2014-11-11 | VSTMVerastem, Inc.P Purchase | +$22.9K |
| 2013-06-12 | CUBIST PHARMACEUTICALS INCRestricted Stock UnitsA Award | — |
| 2013-06-12 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award | — |
| 2013-06-12 | CUBIST PHARMACEUTICALS INCA Award | — |
| 2013-06-07 | TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2013-06-06 | CUBIST PHARMACEUTICALS INCM Exercise/Conversion | — |
| 2013-06-06 | CUBIST PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion | — |
| 2013-06-04 | VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award | — |
| 2013-06-04 | VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award | — |
| 2013-03-07 | TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2012-11-26 | VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award | — |
| 2012-06-06 | CUBIST PHARMACEUTICALS INCRestricted Stock UnitsA Award | — |
| 2012-06-06 | CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award | — |
Recent filings
- 4Lawton Alison Frances0001542650-26-000002SEC(opens sec.gov)
- 4Lawton Alison Frances0000950170-25-076403SEC(opens sec.gov)
- 4Lawton Alison Frances0001628280-24-027672SEC(opens sec.gov)
- 4Lawton Alison Frances0000950170-24-065540SEC(opens sec.gov)
- 4Lawton Alison Frances0000899243-23-018867SEC(opens sec.gov)
- 4Lawton Alison Frances0001209191-23-040328SEC(opens sec.gov)
- 4Lawton Alison Frances0001628280-23-022084SEC(opens sec.gov)
- 4Lawton Alison Frances0000899243-22-024675SEC(opens sec.gov)
- 4Lawton Alison Frances0001628280-22-018054SEC(opens sec.gov)
- 4Lawton Alison Frances0001209191-22-035691SEC(opens sec.gov)
- 4Lawton Alison Frances0001209191-21-039228SEC(opens sec.gov)
- 4Lawton Alison Frances0000899243-21-021848SEC(opens sec.gov)
- 4Lawton Alison Frances0001628280-21-011543SEC(opens sec.gov)
- 4Lawton Alison Frances0000899243-20-035052SEC(opens sec.gov)
- 4Lawton Alison Frances0001209191-20-064066SEC(opens sec.gov)
- 4Lawton Alison Frances0001628280-20-014324SEC(opens sec.gov)
- 4Lawton Alison Frances0000899243-20-010884SEC(opens sec.gov)
- 4Lawton Alison Frances0000899243-20-006859SEC(opens sec.gov)
- 4Lawton Alison Frances0000899243-19-027503SEC(opens sec.gov)
- 4Lawton Alison Frances0001104659-19-037502SEC(opens sec.gov)
Companies
- CoLucid Pharmaceuticals, Inc.Director
- CUBIST PHARMACEUTICALS INCDirector
- Dianthus Therapeutics, Inc. /DE/DirectorDNTH
- Kaleido Biosciences, Inc.Director, See Remarks
- ProQR Therapeutics N.V.DirectorPRQR
- Spyre Therapeutics, Inc.DirectorSYRE
- Tempest Therapeutics, Inc.Chief Operating OfficerTPST
- Verastem, Inc.DirectorVSTM
- X4 Pharmaceuticals, IncDirectorXFOR
Address
C/O DIANTHUS THERAPEUTICS, INC. 7 TIMES SQUARE, 43RD FLOOR
NEW YORK, NY, 10036